The Association Between Clinically Diagnosed Neonatal Jaundice and Autism: A Swedish Register-Based Cohort StudyShow others and affiliations
2025 (English)In: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 114, no 11, p. 2925-2934Article in journal (Refereed) Published
Abstract [en]
AIM: Neonatal jaundice may increase the likelihood of autism through its influence on neurodevelopment. We assessed whether neonatal jaundice increases the risk for autism while accounting for confounding of perinatal risk factors.
METHOD: We used a population-based cohort of 1 669 830 individuals born in Sweden between 1992 and 2010. Information on jaundice and autism was retrieved from Swedish registers. Participants were followed from the age of 3, with available follow-up until 2013. We used Cox regression to estimate the hazard ratios (HRs) relating autism to neonatal jaundice.
RESULTS: Prior to accounting for covariates such as prenatal and perinatal factors, we observed an association between neonatal jaundice and autism (HR = 1.48, 95% CI: 1.37-1.60). This association significantly weakened after adjusting for potential confounders, particularly gestational age and birth weight. After adjusting for all covariates, the association nullified (HR = 1.02, 95% CI: 0.93-1.12).
CONCLUSION: The association between neonatal jaundice and autism is confounded, in particular by preterm birth. Our results highlight the importance of accounting for perinatal confounders when investigating the link between early life factors and autism, which may not always be genetic or familial.
Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2025. Vol. 114, no 11, p. 2925-2934
Keywords [en]
autism, delayed effects, jaundice, prenatal exposure
National Category
Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-122280DOI: 10.1111/apa.70191ISI: 001520327500001PubMedID: 40590769Scopus ID: 2-s2.0-105009816808OAI: oai:DiVA.org:oru-122280DiVA, id: diva2:1981415
Funder
Swedish Research Council, 2018-02119Forte, Swedish Research Council for Health, Working Life and Welfare, 2022-00126NordForsk, 147 386Swedish Research Council, 2023-02543Forte, Swedish Research Council for Health, Working Life and Welfare, 2023-00678Riksbankens Jubileumsfond, P23-0640
Note
Funding Agencies:
Dr. Rosenqvist is supported by the Jeanssons Foundation (Grant: JS2018-0006). Dr. Rosenqvist and Aleksandra Kanina is also supported by the Swedish Research Council (Grant: 2018-02119). Dr. Butwicka was supported by the Swedish Research Council for Health, Working life and Welfare (Grant: 2022-00126) and Nordforsk (Grant: 147 386). Dr. Taylor is supported by the Swedish Research Council (Grant: 2023-02543). Dr. Rado is supported by the Swedish Research Council for Health, Working life and Welfare (Grant: 2023-00678) and Stiftelsen Riksbankens Jubileumsfond (Grant: P23-0640).
2025-07-042025-07-042026-01-23Bibliographically approved